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NZB  x  NZW hybrid mice provide an excellent model of spontaneous autoim- 
mune disease,  showing a very high incidence of a renal disorder which closely 
resembles  lupus  nephritis  (1).  The  occurrence  of an  autoimmune  condition, 
causing  early  death  from  renal  failure,  in  the  hybrid  of two in-bred  strains 
which do not themselves  show the disorder provides a  unique opportunity for 
elucidating  the  genetic  basis  of inherited  autoimmune  disease.  The  NZB  x 
NZW renal disease must depend on the action of at least two genes, one from 
each  strain,  and  these  genes  must  be  dominant  or codominant  in  that  they 
express their effect in the heterozygous state. 
In  an  earlier  paper  (2)  we  reported  the  results  of a  study  of the  genetic 
contribution of the NZB mouse to the renal disease of the NZB  x  NZW hybrid, 
demonstrating  that  the  NZB  strain  contributes  a  single  gene  or  cluster  of 
closely-linked  genes  to  the  disorder.  In  this  paper  we  report  a  study  of the 
genetic contribution of the NZW strain to the renal disease of the hybrid. 
Materials and Methods 
Mice.  All mice were derived from the Otago University inbred colonies. Virgin female mice 
were used in all the studies described. Female (NZB  × NZW)F1 hybrid mice were backcrossed to 
NZB mice and 150 offspring were H-2 typed and monitored for the onset of renal disease by using 
the criteria described below. In addition (NZB  x  NZW)F1 mice were out-crossed to NZC mice and 
190  offspring were  similarly  studied.  Three  control groups,  comprising 143  (NZB  x  NZW)F~ 
hybrids, 75 NZB, and 40 NZW mice were also monitored for the occurrence of renal disease. 
H-2  Typing.  The H-2  phenotype of each (NZB  x  NZW)F~  ×  NZB  mouse and of 100  of the 
(NZB  ×  NZW)F1  ×  NZC  mice  was  determined by  using  a  modification of Stimpfling's PVP 
hemagglutination technique (3) as described previously (2).  Anti-H-2.4 and anti-H-2.5 antisera, 
kindly supplied by Dr. J. G. Ray, Transplantation and Immunology Branch, National Institute of 
Allergy and  Infectious Diseases,  National  Institutes  of Health,  Bethesda,  Md.  were  used to 
differentiate between H.2 d and H-2" haplotypes. 
Monitoring  Renal Dysfunction 
MEASUREMENT  OF PROTEINURIA.  The onset of renal disease  was monitored by fortnightly 
testing  for proteinuria  by using the method described previously (2).  Briefly,  10-~I  samples of 
urine were spotted onto strips  of chromatography paper,  fixed  in ethanol, and stained with 
bromophenol blue.  The degree of  proteinuria  in each mouse was assessed  by visually  comparing 
the color  intensity  of  the urine spots  with  that  of  spots  of  bovine  serum albumin standards (3,000, 
1,000,  333,  111,  and 37 rag/100  ml that had been similarly  treated. 
MEASUREMENT  OF RENAL CLEARANCE.  Detection of heavy proteinuria (333  mg/100 ml) was 
followed  by the assessment of  glomerular function  with a single  injection  ~ICr-EDTA clearance 
method (2).  Studies on healthy 12-wk old mice established  the normal half-value  time as 14.0  ± 
3.1 min. A  half-value  time of greater than twice the normal value was arbitrarily  chosen as 
indicative  of  severe renal impairment (3). 
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FIG.  1.  A  comparison of the cumulative incidence of severe rena] impairment in NZB  × 
NZW mice and in the reciprocal hack-crosses. 
Results 
Incidence  of Renal  Disease  in  NZB,  NZW,  and  NZB  × NZW Mice.  By 
using the criteria outlined above we observed 6 of 75 NZB mice (8%) and 1 of 40 
NZW mice to have severe renal disease before the age of 440 days. In striking 
contrast, 130 of 143 (NZB x  NZW)F1  mice (92%) had severe renal disease before 
440 days.  We observed a  continuing occurrence of renal disease in older NZB 
mice, the incidence reaching 16% by 540 days. 
Incidence of  Renal Disease in (NZB × NZW)FI × NZB Backcross Mice.  Fig. 
1 shows that the incidence of renal disease in the group of 150 (NZB ×  NZW)  × 
NZB backcross mice reached 32.7% by 440 days. As we have observed a  small, 
but  significant,  incidence of early renal  disease  in  NZB  mice  we  consider it 
more likely that this represents an over-estimate of 25% than an under-estimate 
of  50%  incidence  of  early  renal  disease  in  this  backcross.  This  view  is 
strengthened  by the  observation that  there  was  a  marked  difference in  the 
distribution of ages of onset of renal disease in the mice of this backcross as 
compared to the NZB x  NZW animals, with some of the backcross mice showing 
a  tendency towards  later onset of renal  disease  as  occurs in the  NZB strain. 
Thus 14 of 49 backcross mice developed renal disease when older than 360 days 
as compared to 2 of 130 NZB  ×  NZW mice (X  ~ =  28.7, P  <  0.001). 
These  data,  together  with  those  of  our  earlier  study  (2),  are  therefore 
compatible with the conclusion that the renal disease of  the NZB z  NZW hybrid 
is determined by three genes, all dominant or codominant, one contributed by 
the NZB strain and two,  unlinked, contributed by the NZW strain.  We have 
designated  these  three  genes  LN-1  (lupus  nephritis-i), 1  LN-2,  and  LN-3, 
respectively (see Fig. 2). 
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FIG. 2.  Three genes for lupus nephritis (LN-1, LN-2, and LN-3), all dominant, in NZB × 
NZW mice. LN-1, LN-2, and LN-3 could represent clusters of closely  linked  genes  rather 
than single loci. 
TABLE  I 




H.2  I/H.2  ~  H.2  ,I /H_2,1 
Mice with renal disease  43  6  49 
Mice without renal disease  35  66  101 
Total  78  72  150 
Linkage  between  the  H-2  Complex  and  One  of  the  NZW  Renal  Disease 
Genes.  The mice of the  (NZB  x  NZW)  x  NZB backcross would be expected to 
be either homozygous (H-2a/H-2 d) or heterozygous (H-2a/H-2 z) with respect to 
the H-2  complex (NZBs are H-2 d,  NZWs are H-2 ~)  (4).  Table  1 shows that,  as 
expected, the 150 mice were nearly equally divided between the two genotypes. 
However,  a  great  preponderance  of mice which  developed renal  disease  were 
heterozygous.  This difference  is  highly  significant  (X"  =  35.2,  P  <  0.001)  and 
indicates that one of the  genes contributed by the NZW strain is linked to the 
H-2  complex. The occurrence of renal disease in H-2d/H-2 ~1 mice could indicate 
that  there  is  a  crossover  frequency  of approximately  8%  between  the  renal 
disease gene and the D  end of the H-2 complex, the side on which the new gene 
lies  being  undetermined.  However,  as  already  indicated,  a  small  proportion 
(8%) of NZB mice develop early severe renal disease and these are indistinguish- 
able  from  NZB  x  NZW  mice on  the  basis  of the  criteria  used  in  this  study. 
Therefore it seems more probable that the six homozygous mice showing renal 
disease  are  not the  result  of crossover and  that this  NZW renal  disease gene, 
which  we have designated  LN-2,  is very closely linked  to the H-2  complex as 
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Incidence  of Renal  Disease  in  (NZB  x  NZW)FI  x  NZC  Mice.  NZC  mice 
have not been found to show any incidence of autoimmune lupus nephritis (5), 
so the incidence of renal disease in the  (NZB  x  NZW)  x  NZC out-cross was 
studied as an independent test for linkage between renal disease genes from the 
NZB and the NZW strains. If the gene contributed by the NZB strain is on the 
same chromosome as one from the NZW strain then renal disease would only 
occur  if there  was crossingover between them.  We  observed  10  of 190  mice 
(5.3%) of this out-cross to develop renal disease. This figure approximates the 
7.5% incidence which one would expect if the renal disease were determined by 
two dominant unlinked genes (A and B) from one strain and one dominant gene 
(C) from the other strain, linked to gene A but separated from it by a crossover 
frequency of 30%. 
Only  100  of the  190  mice were H.2  typed before  some  mice  died  of renal 
failure. However all six of the mice which developed renal disease and which 
had been typed were H-2 ~lz, (NZC mice are H-2 ~) (6) which suggests that (one 
of) the gene(s) from the NZW is closely linked to the H-2  complex. Thus the 
data obtained from this out-cross provide independent confirmation of the data 
obtained from the reciprocal backcrosses. 
Discussion 
In cross-breeding studies of the NZB mice with other inbred New  Zealand 
strains,  Helyer and Howie  (7) observed that NZB  x  New Zealand Yellow F1 
hybrids showed only a  very low  incidence of hemolytic anemia and positive 
Coombs tests (4%) but died prematurely with renal lesions similar to those seen 
in lupus nephritis.  Subsequently Helyer and Howie (8)  reported that NZB  x 
NZW mice die even more prematurely from a similar lupus nephritis. Positive 
lupus erythematosus cell tests were observed in both hybrids (8). It was shown 
by fluorescence techniques that  NZB  x  NZW  hybids have  accumulations of 
immunoglobulins in the glomeruli (9,  10), together with complement (10), and 
elution  studies  have  shown  that  the  immunoglobulins have  specificity for 
nuclear antigens in accord with the concept that the renal lesions are caused by 
immune complexes of nuclear antigens and their complement-fixing autoanti- 
bodies which become trapped in the glomeruli (10). 
NZB  and NZW mice from the  Otago colonies do not show the early renal 
failure characteristic of the NZB  x  NZW hybrids. Howie and Helyer (1) found 
no heavy proteinuria in  270  virgin female NZB  mice at  1 yr of age  and we 
observed an incidence of only 4% in a similar group of 75 NZB mice aged 1 yr. 
Similarly we  have  observed  only a  very low  incidence  (2.5%) of early renal 
disease in 40 NZW mice. 
It  appears  that  renal  disease  and/or  antibodies  directed  against  nuclear 
components are found much more commonly in colonies of NZB and NZW mice 
elsewhere in the world. Thus reports on anti-nuclear antibody incidence in NZB 
mice have varied from almost 0 to 100% (1,  11-16).  It is highly relevant that 
many of the authors reporting a high incidence of anti-nuclear antibody (ANA) 
in NZB mice have also observed considerable frequencies of ANA in unrelated 
strains, suggesting that environmental factors could be largely responsible, as 
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Dixon et al.  (19) demonstrated that virus infections could cause nephritis in 
normal mouse strains as a result of deposition of viral-anti-viral-antibody com- 
plexes in glomeruli. The presence of C-type particles indicative of murine leu- 
kemia virus in NZB mice appears to be widely accepted as a normal attribute 
of the strain. However, C-type particles have never been observed in mice from 
the Otago colony despite extensive electron microscope studies (20) and serologi- 
cal testing of serum samples from the Otago colonies has failed to reveal the 
presence of active murine leukemia virus,  T.  Maguire, personal communica- 
tion.  Differences in viral infestations could well explain many of the discrep- 
ancies in the literature on the NZB mouse and its hybrids. 
It now seems clear that the autoimmunity is not due to virus infection in that 
it cannot be transmitted by cell-free filtrates (21, 22) or enhanced by immune 
suppression  (23, 24). On the other hand,  the lymphoid tumours which occur 
with widely varying frequency in different NZB colonies (21) do appear to be 
caused by oncogenic viruses  in  that their frequency is  greatly increased by 
immune suppression (23, 25) and they appear to have been transmitted by cell- 
free filtrates (26) as well as by living cells (27, 28). It seems likely that these 
lymphoid tumours are unrelated to the autoimmunity (23). 
Our previous study (2) showed a  50% incidence of severe early renal disease 
in (NZB  x  NZW)  x  NZW backcross animals, indicating that the NZB strain 
contributes a  single gene, or cluster of closely-linked genes, to the condition. 
This gene was found to be loosely linked to the H-2  complex (see Fig. 2).  The 
present study, showing a 25% incidence of early renal disease in (NZB x  NZW) 
x  NZB  backcross  animals,  indicates  that  the  NZW  strain  contributes  two 
unlinked genes. However, additional genes, common to both the NZB and the 
NZW strains,  could also be involved in the lupus nephritis.  One of the NZW 
genes was found to be closely linked to the H-2 complex (Fig. 2) and could be a 
histocompatibility-linked immune response (H-Ir) gene (29). Of interest in this 
regard is the observation of Lambert and Dixon (30) that NZW mice are high 
responders  to  heat  denatured  DNA  coupled  to  methylated  bovine  serum 
albumin, and that high responder status is transferred in dominant fashion to 
the NZB  x  NZW hybrid (NZBs are low responders to DNA). 
All three of the genes whose effect we have observed must be dominant or 
codominant in that their effect is expressed  in the heterozygous state.  From 
consideration of the features and pattern of inheritance of thyroid and other 
human autoimmune diseases one of us (31) has postulated that the genetic basis 
of inherited autoimmune disease lies in the specificity of V genes, the structural 
genes which code for the variable portions of the light and heavy polypeptide 
chains which combine to form antibody molecules (32). We consider that the 
genes LN-1 and LN-3 are most likely to be immunoglobulin V genes in accord 
with this concept. It is possible that LN-1 is a  light chain V gene and LN-3 a 
heavy chain V  gene which,  in combination, code for an autoantibody in the 
NZB  x  NZW hybrid (Fig. 2). The crossover frequency between LN-1 and the D 
end of H-2, 32.6% (2), is very close to that (31.4%) for a gene observed by Lotzova 
and Cudkowicz (33) to control resistance to bone marrow grafts in mice. These 
two genes could be members of a single cluster of V genes. 
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of an age-dependent loss of suppressor T  cells,  which are supposed to prevent 
production of autoantibodies  in  normal  animals  (34,  35).  It has  been claimed 
that  suppression  or prevention of autoantibody formation can  be  achieved in 
mice  of strains  which  develop  autoimmunity  by  injecting  thymocytes  from 
young  syngeneic  donors  (36,  38).  However,  we  have  been  unable  to  confirm 
these findings in NZB and NZB  x  NZW mice." Furthermore, it is difficult to see 
how such a proposal could be compatible with present knowledge of the genetic 
basis  of autoimmune  diseases.  The  pattern  of inheritance  of human  autoim- 
mune diseases  is dominant with incomplete penetrance and for thyrotoxicosis 
and diabetes there is evidence that at least two genes are involved, suggesting 
a  basis  in  pairs  of immunoglobulin  V  genes  (31)  and  making  an  interesting 
parallel with the present data. 
Summary 
The occurrence of early severe lupus nephritis in (NZB  x  NZW)F1 mice must 
depend on the action of at least two dominant or codominant genes (at least one 
gene  from  each  parent)  as  neither  of the  inbred  parental  strains  shows  the 
disorder.  Identifying affected animals  by antemortem determinations of renal 
function,  we  have  studied  the  incidence  of the  renal  disease  in  230  (NZB  x 
NZW)  x  NZW backcross mice (an earlier study) and, in this study, in 150 (NZB 
x  NZW)  x  NZB  backcross  mice.  The  data  indicate  that  the  NZB  strain 
contributes only one gene and the NZW strain contributes two genes, or clusters 
of closely linked genes, to the renal disorder of the FI hybrid.  One of the NZW 
genes  was  found  to  be  linked  to  the H-2  complex.  All  three  genes  must  be 
dominant or codominant, as their effect is expressed in the heterozygous state. 
We are grateful to Ms. Fiona McKenzie, Ms. Judith Burborough, and Mr. W. S.  Cague for excel- 
lent technical assistance. 
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